Clinical Trials

Showing trials with last updates posted in 2021.

NCT02955069 | COMPLETED | PHASE2
116 participants

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Study Type:
INTERVENTIONAL
Last Updated:
2021-04-12
Start Date:
2017-02-14
Completion:
2018-08-10
Conditions
  • Well-differentiated Non-functional NET of Thoracic Origin
  • Well-differentiated Non-functional NET of Gastrointestinal Origin
  • Well-differentiated Non-functional NET of Pancreatic Origin
  • Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page